PL373257A1 - Pochodne hydroksytetrahydro-naftalenylomocznika - Google Patents
Pochodne hydroksytetrahydro-naftalenylomocznikaInfo
- Publication number
- PL373257A1 PL373257A1 PL03373257A PL37325703A PL373257A1 PL 373257 A1 PL373257 A1 PL 373257A1 PL 03373257 A PL03373257 A PL 03373257A PL 37325703 A PL37325703 A PL 37325703A PL 373257 A1 PL373257 A1 PL 373257A1
- Authority
- PL
- Poland
- Prior art keywords
- pain
- tetrahydro
- useful
- treatment
- naphthalene derivatives
- Prior art date
Links
- GYUVMUDBAKAYON-UHFFFAOYSA-N 1-hydroxy-1-(1,2,3,4-tetrahydronaphthalen-1-yl)urea Chemical class C1=CC=C2C(N(O)C(=O)N)CCCC2=C1 GYUVMUDBAKAYON-UHFFFAOYSA-N 0.000 title 1
- 208000002193 Pain Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000004296 neuralgia Diseases 0.000 abstract 2
- CXWXQJXEFPUFDZ-UHFFFAOYSA-N tetralin Chemical class C1=CC=C2CCCCC2=C1 CXWXQJXEFPUFDZ-UHFFFAOYSA-N 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 206010021639 Incontinence Diseases 0.000 abstract 1
- 208000028389 Nerve injury Diseases 0.000 abstract 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 1
- 208000004550 Postoperative Pain Diseases 0.000 abstract 1
- 208000006011 Stroke Diseases 0.000 abstract 1
- 208000000921 Urge Urinary Incontinence Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 230000002917 arthritic effect Effects 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000028867 ischemia Diseases 0.000 abstract 1
- 230000008764 nerve damage Effects 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 201000001119 neuropathy Diseases 0.000 abstract 1
- 230000007823 neuropathy Effects 0.000 abstract 1
- 208000020629 overactive bladder Diseases 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0210512.0A GB0210512D0 (en) | 2002-05-08 | 2002-05-08 | Tetrahydro-napthalene derivatives |
| GBGB0227262.3A GB0227262D0 (en) | 2002-05-08 | 2002-11-21 | Tetrahydro-naphthalene derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL373257A1 true PL373257A1 (pl) | 2005-08-22 |
| PL210288B1 PL210288B1 (pl) | 2011-12-30 |
Family
ID=29422108
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL373257A PL210288B1 (pl) | 2002-05-08 | 2003-04-28 | Pochodne hydroksytetrahydro-naftalenylomocznika, leki je zawierające i ich zastosowanie do wytwarzania leków |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7612113B2 (pl) |
| EP (1) | EP1506167B1 (pl) |
| JP (1) | JP4335131B2 (pl) |
| CN (1) | CN1307150C (pl) |
| AT (1) | ATE371641T1 (pl) |
| AU (1) | AU2003229734B2 (pl) |
| BR (1) | BR0309940A (pl) |
| CA (1) | CA2487238C (pl) |
| DE (1) | DE60315973T2 (pl) |
| DK (1) | DK1506167T3 (pl) |
| ES (1) | ES2292959T3 (pl) |
| HR (1) | HRP20041167A2 (pl) |
| IL (1) | IL165004A (pl) |
| MX (1) | MXPA04010938A (pl) |
| NO (1) | NO20045359L (pl) |
| NZ (1) | NZ536418A (pl) |
| PL (1) | PL210288B1 (pl) |
| RU (1) | RU2331635C2 (pl) |
| TW (1) | TWI271396B (pl) |
| WO (1) | WO2003095420A1 (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004028440A2 (en) * | 2002-09-24 | 2004-04-08 | Bayer Healthcare Ag | Vr1 antagonists for the treatment of urological disorders |
| CA2508618C (en) | 2002-12-06 | 2012-02-21 | Bayer Healthcare Ag | Tetrahydro-naphthalene derivatives |
| AU2003288200A1 (en) * | 2002-12-09 | 2004-06-30 | Bayer Healthcare Ag | Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists |
| EP1679296A4 (en) | 2003-10-14 | 2007-12-26 | Ajinomoto Kk | DERIVE ETHERE |
| EP1678123A1 (en) * | 2003-10-15 | 2006-07-12 | Bayer HealthCare AG | Tetrahydro-naphthalene and urea derivatives |
| WO2005044802A2 (en) * | 2003-11-08 | 2005-05-19 | Bayer Healthcare Ag | Tetrahydro-quinolinylurea derivatives as vrl antagonists |
| WO2005095329A1 (en) * | 2004-03-31 | 2005-10-13 | Pfizer Japan Inc. | Substituted benzamide compounds as vr1 receptor antagonists |
| EP1893189A2 (en) * | 2005-03-05 | 2008-03-05 | Bayer HealthCare AG | Use of hydroxy tetrahydro-naphthalene derivatives for the treatment of respiratory diseases |
| AU2006225496A1 (en) | 2005-03-19 | 2006-09-28 | Amorepacific Corporation | Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same |
| DE102005017286B3 (de) * | 2005-04-14 | 2006-12-28 | Schering Ag | Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| DE102005023943A1 (de) | 2005-05-20 | 2006-11-23 | Grünenthal GmbH | Pentafluorsulfanyl-substituierte Verbindung und deren Verwendung zur Herstellung von Arzneimitteln |
| JP2010513557A (ja) * | 2006-12-20 | 2010-04-30 | アボット・ラボラトリーズ | 疼痛治療のためのｔｒｐｖ１バニロイド受容体アンタゴニストとしてのｎ−（５，６，７，８−テトラヒドロナフタレン−１−イル）尿素誘導体および関連化合物 |
| WO2008096755A1 (ja) * | 2007-02-07 | 2008-08-14 | Nippon Suisan Kaisha, Ltd. | バニロイド受容体（ｖｒ１）阻害剤及びその用途 |
| DE102009055915A1 (de) * | 2009-11-27 | 2011-06-01 | Beiersdorf Ag | Verwendung von Zingeron zur Herstellung kosmetischer oder dermatologischer Zubereitungen, welche auf der Haut ein Prickeln hervorrufen |
| WO2021039023A1 (ja) | 2019-08-23 | 2021-03-04 | 持田製薬株式会社 | ヘテロシクリデンアセトアミド誘導体の製造方法 |
| DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9713484D0 (en) | 1997-06-27 | 1997-09-03 | Smithkline Beecham Plc | Neuroprotective vanilloid compounds |
| GB9727532D0 (en) * | 1997-12-23 | 1998-02-25 | Rh Ne Poulenc Rorer Limited | Chemical compounds |
| US6333337B1 (en) * | 1998-01-27 | 2001-12-25 | Icagen, Inc. | Potassium channel inhibitors |
| EP1154989B1 (en) * | 1999-02-22 | 2005-12-14 | Pacific Corporation | Vanilloid analogues containing resiniferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof |
| HUP0200996A3 (en) | 1999-04-07 | 2003-01-28 | Sankyo Company Ltd Chuo Ku | Amine derivatives, pharmaceutical compositions containing them and their use |
| US6294694B1 (en) | 1999-06-04 | 2001-09-25 | Wisconsin Alumni Research Foundation | Matrix metalloproteinase inhibitors and method of using same |
| CA2508618C (en) * | 2002-12-06 | 2012-02-21 | Bayer Healthcare Ag | Tetrahydro-naphthalene derivatives |
| EP1493438A1 (en) * | 2003-07-03 | 2005-01-05 | Bayer HealthCare AG | Vanilloid receptor (VR) inhibitors for treatment of Human Immunodeficiency Virus (HIV)-mediated pain states |
| EP1678123A1 (en) * | 2003-10-15 | 2006-07-12 | Bayer HealthCare AG | Tetrahydro-naphthalene and urea derivatives |
| DE602004017892D1 (de) * | 2003-11-08 | 2009-01-02 | Bayer Healthcare Ag | Bicyclische amid-, carbamat- oder harnstoffderivate als modulatoren des vanilloidrezeptors |
-
2003
- 2003-04-28 EP EP03722554A patent/EP1506167B1/en not_active Expired - Lifetime
- 2003-04-28 MX MXPA04010938A patent/MXPA04010938A/es active IP Right Grant
- 2003-04-28 NZ NZ536418A patent/NZ536418A/en not_active IP Right Cessation
- 2003-04-28 HR HR20041167A patent/HRP20041167A2/xx not_active Application Discontinuation
- 2003-04-28 PL PL373257A patent/PL210288B1/pl unknown
- 2003-04-28 CA CA2487238A patent/CA2487238C/en not_active Expired - Lifetime
- 2003-04-28 WO PCT/EP2003/004395 patent/WO2003095420A1/en not_active Ceased
- 2003-04-28 JP JP2004503441A patent/JP4335131B2/ja not_active Expired - Lifetime
- 2003-04-28 CN CNB038159880A patent/CN1307150C/zh not_active Expired - Lifetime
- 2003-04-28 ES ES03722554T patent/ES2292959T3/es not_active Expired - Lifetime
- 2003-04-28 DK DK03722554T patent/DK1506167T3/da active
- 2003-04-28 AU AU2003229734A patent/AU2003229734B2/en not_active Expired
- 2003-04-28 US US10/513,848 patent/US7612113B2/en not_active Expired - Lifetime
- 2003-04-28 AT AT03722554T patent/ATE371641T1/de active
- 2003-04-28 BR BR0309940-7A patent/BR0309940A/pt not_active IP Right Cessation
- 2003-04-28 RU RU2004136281/04A patent/RU2331635C2/ru not_active IP Right Cessation
- 2003-04-28 DE DE60315973T patent/DE60315973T2/de not_active Expired - Lifetime
- 2003-05-07 TW TW092112380A patent/TWI271396B/zh not_active IP Right Cessation
-
2004
- 2004-11-03 IL IL165004A patent/IL165004A/en not_active IP Right Cessation
- 2004-12-07 NO NO20045359A patent/NO20045359L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1506167A1 (en) | 2005-02-16 |
| DE60315973T2 (de) | 2008-05-21 |
| ATE371641T1 (de) | 2007-09-15 |
| DK1506167T3 (da) | 2008-01-02 |
| JP2005524717A (ja) | 2005-08-18 |
| CN1665778A (zh) | 2005-09-07 |
| US20060258742A1 (en) | 2006-11-16 |
| MXPA04010938A (es) | 2005-02-14 |
| IL165004A (en) | 2010-12-30 |
| CA2487238A1 (en) | 2003-11-20 |
| US7612113B2 (en) | 2009-11-03 |
| PL210288B1 (pl) | 2011-12-30 |
| ES2292959T3 (es) | 2008-03-16 |
| TWI271396B (en) | 2007-01-21 |
| NO20045359L (no) | 2004-12-07 |
| CN1307150C (zh) | 2007-03-28 |
| RU2004136281A (ru) | 2005-07-10 |
| BR0309940A (pt) | 2005-02-09 |
| EP1506167B1 (en) | 2007-08-29 |
| WO2003095420A1 (en) | 2003-11-20 |
| HK1082946A1 (en) | 2006-06-23 |
| AU2003229734A1 (en) | 2003-11-11 |
| NZ536418A (en) | 2006-04-28 |
| IL165004A0 (en) | 2005-12-18 |
| AU2003229734B2 (en) | 2009-02-19 |
| TW200404052A (en) | 2004-03-16 |
| HRP20041167A2 (en) | 2005-08-31 |
| DE60315973D1 (de) | 2007-10-11 |
| JP4335131B2 (ja) | 2009-09-30 |
| RU2331635C2 (ru) | 2008-08-20 |
| CA2487238C (en) | 2011-03-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003294748A1 (en) | Tetrahydro-naphthalene derivatives | |
| IL165004A0 (en) | Hydroxy tetrahydro-naphthalenylurea derivatives | |
| WO2003055848A3 (en) | Urea derivatives as vr1- antagonists | |
| WO2003014064A8 (en) | Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists | |
| WO2009109618A3 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 | |
| WO2005112970A3 (en) | Use of gelsolin to treat infections | |
| WO2009109616A3 (en) | 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cxrl and p40 | |
| AU2003288200A1 (en) | Tetrahydro-naphthalene derivatives as vanilloid receptor antagonists | |
| IL193628A0 (en) | Methods and compositions for bactericide, bacteriostatic and anti-inflammation | |
| IL187438A0 (en) | Pyrrolopyridine derivatives and pharmaceutical compositions containing the same | |
| WO2009109654A8 (en) | 1-benzyl-3-hydr0xymethylindaz0le derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, and cx3cr1 | |
| WO2006074265A3 (en) | Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders | |
| WO2007053495A3 (en) | Compounds useful as antagonists of ccr2 | |
| GB2427405A (en) | Novel hydroxamates as therapeutic agents | |
| WO2005044802A3 (en) | Tetrahydro-quinolinylurea derivatives as vrl antagonists | |
| WO2007140181A3 (en) | Combination therapy comprising an adenosine uptake inhibitor and a non-selective adenosine receptor antagonist | |
| MY155011A (en) | Hydroxy tetrahydro-naphthalenylurea derivatives | |
| WO2007062862A3 (en) | Use of calmodulin inhibitors for the treatment of neurodegenerative disorders | |
| WO2012060594A3 (ko) | 티오우레아계 화합물 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 항염증 조성물 | |
| TW200716629A (en) | Pyrazolopyrimidine derivative or pharmaceutically acceptable salt thereof | |
| TH78306A (th) | อนุพันธ์ไฮดรอกซีเททตราไฮโดร-แนพธาลีนิลยูเรีย | |
| UY27794A1 (es) | Derivados de hidroxi tetrahidro-naftalenilurea | |
| WO2008093767A1 (ja) | ベンジルアミン誘導体またはその薬学的に許容される酸付加塩、およびその医薬用途 | |
| TH78306B (th) | "อนุพันธ์ไฮดรอกซีเททตราไฮโดร-แนพธาลีนิลยูเรีย" | |
| ATE442848T1 (de) | Isoxazolsäure-derivat zur linderung neuropathischer schmerzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RECP | Rectifications of patent specification |